Genor Biopharma Holdings Ltd. has announced a further delay in the dispatch of its circular related to several key transactions, including a very substantial acquisition and a proposed merger. The delay pertains to the financial reporting for the period ending December 2024. The announcement does not specify the form type for the delayed financial report.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genor Biopharma Holdings Ltd. published the original content used to generate this news brief on June 26, 2025, and is solely responsible for the information contained therein.